26389232

This PDQ cancer information summary for health professionals provides comprehensive, peer-reviewed, evidence-based information about the treatment of childhood liver cancer. It is intended as a resource to inform and assist clinicians who care for cancer patients. It does not provide formal guidelines or recommendations for making health care decisions.This summary is reviewed regularly and updated as necessary by the PDQ Pediatric Treatment Editorial Board, which is editorially independent of the National Cancer Institute (NCI). The summary reflects an independent review of the literature and does not represent a policy statement of NCI or the National Institutes of Health (NIH).
childhood liver cancer; childhood hepatoblastoma; childhood hepatocellular carcinoma; childhood undifferentiated embryonal sarcoma of the liver; infantile choriocarcinoma of the liver; childhood epithelioid hemangioendothelioma.
